Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study

被引：0
作者：
Wang Mingdong
Gao Xiang
Quan Yongjun
Wang Mingshuai
Ping Hao
机构：
[1] Capital Medical University,Department of Urology, Beijing Tongren Hospital
[2] Capital Medical University,Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital
[3] Chinese Academy of Medical Sciences,Department of Urology, Cancer Hospital
来源：
BMC Cancer | / 23卷
关键词：
Gut microbiota; Bladder cancer; Prostate cancer; Kidney cancer; Mendelian randomization; FinnGen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 183 条
[1]  
Kocarnik JM(2022)Cancer Incidence, Mortality, Years of Life Lost, Years lived with disability, and disability-adjusted life years for 29 Cancer Groups from 2010 to 2019: a systematic analysis for the global burden of Disease Study 2019 JAMA Oncol 8 420-44
[2]  
Compton K(2021)Prostate cancer Nat Rev Dis Primers 7 9-108
[3]  
Dean FE(2017)Bladder Cancer incidence and mortality: A global overview and recent Trends Eur Urol 71 96-84
[4]  
Fu W(2019)Epidemiology of renal cell carcinoma Eur Urol 75 74-6
[5]  
Gaw BL(2015)Cancer and the microbiota Science 348 80-32
[6]  
Harvey JD(2022)Gut microbiome and health: mechanistic insights Gut 71 1020-9
[7]  
Rebello RJ(2016)The gut microbiota and host health: a new clinical frontier Gut 65 330-8
[8]  
Oing C(2022)Gut microbiome and prostate cancer Int J Urol 29 793-509
[9]  
Knudsen KE(2022)3rd. Bladder cancer, inflammageing and microbiomes Nat Rev Urol 19 495-35
[10]  
Loeb S(2021)The gut microbiota activates AhR through the Tryptophan Metabolite Kyn to Mediate Renal Cell Carcinoma Metastasis Front Nutr 8 712327-403
12345678910